Using Omnidirectional Virtual Reality and Treadmill Training for Chronic Stroke
Launched by NOVA SCOTIA HEALTH AUTHORITY · Jul 3, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people who have had a stroke improve their walking and thinking skills. The researchers want to see if using a special virtual reality system combined with a treadmill, called omnidirectional treadmill Virtual Reality (omni-VR), is effective compared to a traditional exercise program that focuses on walking and strengthening activities. They will look at how well participants can walk, their balance, and how their brain works during tasks over three months of training.
To participate in this study, you need to have had a stroke at least six months ago and be living near Halifax, Nova Scotia. You should be able to walk with some limitations and have no major health issues affecting your balance or walking. If you join, you'll attend training sessions for 45 minutes, three times a week, either using the omni-VR system or doing traditional exercises. The researchers will also check how your quality of life and motivation might improve during the trial. This study is currently looking for participants, and it's an opportunity to potentially benefit from innovative rehabilitation techniques.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stroke ≥ 6 months ago (per conventional stroke trials)
- • Living within 50 km of Halifax, Nova Scotia
- • Functional Ambulation Category ≥ 3
- • Self-reported walking limitations (Walk-12 score \> 20)
- • Ability to exercise for ≥ 15 minutes
- • No visual deficits or hemispatial neglect
- • No other cardiovascular, orthopedic, or neurological diseases impacting walking or balance
- • Montreal Cognitive Assessment (MoCA) scores \> 18 indicating moderate or severe cognitive impairment
About Nova Scotia Health Authority
The Nova Scotia Health Authority (NSHA) is a leading healthcare organization dedicated to enhancing the health and well-being of individuals and communities across Nova Scotia, Canada. As the largest provider of health services in the province, NSHA is committed to advancing clinical research and innovation through rigorous clinical trials that aim to improve patient care and outcomes. With a focus on collaboration, NSHA engages healthcare professionals, researchers, and patients to address pressing health challenges and contribute to the global body of medical knowledge. By fostering a culture of evidence-based practice and continual improvement, NSHA plays a pivotal role in shaping the future of healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, Nova Scotia, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported